TFX Quote, Financials, Valuation and Earnings

Boston Scientific Corp. has a net margin of -44.78% compared to Teleflex, Inc.'s net margin of 12.68%. Teleflex, Inc.'s return on equity of -7.84% beat Boston Scientific Corp.'s return on equity of 12.46%.

Teleflex, Inc. has a consensus price target of $129.25, signalling upside risk potential of 19.21%. On the other hand Boston Scientific Corp. has an analysts' consensus of $106.78 which suggests that it could grow by 40%. Given that Boston Scientific Corp. has higher upside potential than Teleflex, Inc., analysts believe Boston Scientific Corp. is more attractive than Teleflex, Inc..

Teleflex, Inc. has a beta of 0.917, which suggesting that the stock is 8.269% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.

Teleflex, Inc. has a quarterly dividend of $0.34 per share corresponding to a yield of 1.25%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex, Inc. pays 91.92% of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend. Teleflex, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Teleflex, Inc. quarterly revenues are $913M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. Teleflex, Inc.'s net income of -$408.9M is lower than Boston Scientific Corp.'s net income of $670M. Notably, Teleflex, Inc.'s price-to-earnings ratio is 25.75x while Boston Scientific Corp.'s PE ratio is 39.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex, Inc. is 1.54x versus 5.68x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Integra LifeSciences Holdings Corp. has a net margin of -44.78% compared to Teleflex, Inc.'s net margin of -1.34%. Teleflex, Inc.'s return on equity of -7.84% beat Integra LifeSciences Holdings Corp.'s return on equity of -37.15%.

Teleflex, Inc. has a consensus price target of $129.25, signalling upside risk potential of 19.21%. On the other hand Integra LifeSciences Holdings Corp. has an analysts' consensus of $15.50 which suggests that it could grow by 37.66%. Given that Integra LifeSciences Holdings Corp. has higher upside potential than Teleflex, Inc., analysts believe Integra LifeSciences Holdings Corp. is more attractive than Teleflex, Inc..

Teleflex, Inc. has a beta of 0.917, which suggesting that the stock is 8.269% less volatile than S&P 500. In comparison Integra LifeSciences Holdings Corp. has a beta of 1.036, suggesting its more volatile than the S&P 500 by 3.641%.

Teleflex, Inc. has a quarterly dividend of $0.34 per share corresponding to a yield of 1.25%. Integra LifeSciences Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex, Inc. pays 91.92% of its earnings as a dividend. Integra LifeSciences Holdings Corp. pays out -- of its earnings as a dividend. Teleflex, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Teleflex, Inc. quarterly revenues are $913M, which are larger than Integra LifeSciences Holdings Corp. quarterly revenues of $402.1M. Teleflex, Inc.'s net income of -$408.9M is lower than Integra LifeSciences Holdings Corp.'s net income of -$5.4M. Notably, Teleflex, Inc.'s price-to-earnings ratio is 25.75x while Integra LifeSciences Holdings Corp.'s PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex, Inc. is 1.54x versus 0.53x for Integra LifeSciences Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Insulet Corp. has a net margin of -44.78% compared to Teleflex, Inc.'s net margin of 12.4%. Teleflex, Inc.'s return on equity of -7.84% beat Insulet Corp.'s return on equity of 18.92%.

Teleflex, Inc. has a consensus price target of $129.25, signalling upside risk potential of 19.21%. On the other hand Insulet Corp. has an analysts' consensus of $369.64 which suggests that it could grow by 52.79%. Given that Insulet Corp. has higher upside potential than Teleflex, Inc., analysts believe Insulet Corp. is more attractive than Teleflex, Inc..

Teleflex, Inc. has a beta of 0.917, which suggesting that the stock is 8.269% less volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.412, suggesting its more volatile than the S&P 500 by 41.175%.

Teleflex, Inc. has a quarterly dividend of $0.34 per share corresponding to a yield of 1.25%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex, Inc. pays 91.92% of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend. Teleflex, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Teleflex, Inc. quarterly revenues are $913M, which are larger than Insulet Corp. quarterly revenues of $706.3M. Teleflex, Inc.'s net income of -$408.9M is lower than Insulet Corp.'s net income of $87.6M. Notably, Teleflex, Inc.'s price-to-earnings ratio is 25.75x while Insulet Corp.'s PE ratio is 70.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex, Inc. is 1.54x versus 6.94x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Stryker Corp. has a net margin of -44.78% compared to Teleflex, Inc.'s net margin of 11.84%. Teleflex, Inc.'s return on equity of -7.84% beat Stryker Corp.'s return on equity of 15.17%.

Teleflex, Inc. has a consensus price target of $129.25, signalling upside risk potential of 19.21%. On the other hand Stryker Corp. has an analysts' consensus of $424.40 which suggests that it could grow by 18.45%. Given that Teleflex, Inc. has higher upside potential than Stryker Corp., analysts believe Teleflex, Inc. is more attractive than Stryker Corp..

Teleflex, Inc. has a beta of 0.917, which suggesting that the stock is 8.269% less volatile than S&P 500. In comparison Stryker Corp. has a beta of 0.873, suggesting its less volatile than the S&P 500 by 12.679%.

Teleflex, Inc. has a quarterly dividend of $0.34 per share corresponding to a yield of 1.25%. Stryker Corp. offers a yield of 0.95% to investors and pays a quarterly dividend of $0.88 per share. Teleflex, Inc. pays 91.92% of its earnings as a dividend. Stryker Corp. pays out 40.48% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Teleflex, Inc. quarterly revenues are $913M, which are smaller than Stryker Corp. quarterly revenues of $7.2B. Teleflex, Inc.'s net income of -$408.9M is lower than Stryker Corp.'s net income of $849M. Notably, Teleflex, Inc.'s price-to-earnings ratio is 25.75x while Stryker Corp.'s PE ratio is 42.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex, Inc. is 1.54x versus 5.51x for Stryker Corp.. Usually stocks with elevated PS ratios are considered overvalued.